Dr. Fares Arguello, MD

Radiant ResearchCincinnati, Ohio - 45249 (513-247-5577) |
- CLINICAL TRIALS 1
- CONDITIONS3
- INTERVENTIONS1
- SINCE2010

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
June 2010 - July 2012
Depression
Depressive Disorder
Depressive Disorder, Major
Agomelatine



